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SUMMARY  
Indoor air quality guidelines (IAQGs) provide safe levels of indoor pollutant concentrations 
below which adverse health effects are not expected to occur in the general population, 
including susceptible groups.  
The development of French IAQGs has been on-going since 2005 in the framework of the 
National Environment and Health Action Plan (NEHAP, 2004-2008).  
According to toxicological and epidemiological data, benzene inhalation leads to acute and 
chronic effects. For long-term exposure, haematological effects and leukaemia have been 
observed in the Pliofilm cohort. Benzene is classified as carcinogenic for humans and its 
genotoxic effects have been demonstrated.  
Considering non carcinogenic effects and available toxicological reference values for 
benzene, the IAQG of 10 g.m-3 is proposed to protect the general population for long-term 
exposure. To protect from carcinogenic effects, the proposed IAQGs are based on WHO’s 
potency slope factor: 2 and 0.2 g.m-3 respectively associated with an excess lifetime risk of 
10-5 and 10-6. 
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INTRODUCTION 
In France, indoor pollutant levels have been considerably investigated in different 
environments (homes, schools, offices…) over the last few years. While the health effects of 
outdoor air pollution have been widely studied, health effects of indoor exposures need to be 
assessed. There is also a lack of reference values to facilitate management of indoor air 
quality. In this context, it seems necessary to promote the development of specific health-
based indoor air quality guidelines (IAQGs). 
 
Many countries already have guideline values, and the World Health Organization is currently 
developing IAQGs (WHO, 2006). At the European Union level, the INDEX project 
(supported by the Directorate General for Health and Consumers DG-SANCO) elaborated 
IAQGs for 13 priority chemical pollutants in 2004 (Koistinen et al., 2008). In order to update 
if necessary, or to extend the approach to other compounds, the French Agency for 
Environmental and Occupational Health Safety (AFSSET) and the French Scientific and 
Technical Centre for Building (CSTB) have been leading a multi-partner working group in 
charge of the development of IAQGs based on health criteria.  
 
  
As a first step, the methodological approach was developed and a list of substances of concern 
was established; this list included benzene as high priority compound (AFSSET, 2007a).  
Benzene comes from outdoor air (exhaust fumes from mobile sources) and from indoor 
sources such as combustion (heating, cooking, incense burning, smoking...), attached garages, 
building materials and furniture, storage of solvents, etc. Inhalation is the main route of 
exposure for the general population (EC-JRC, 2004). In French residences, benzene 
concentrations in bedrooms range from 0.4 to 22.8 g.m-3 (mean over 7 days), with a median 
of 2.1 g.m-3 (study in 2003-2005, passive sampling, 541 residences) (Kirchner et al., 2007). 
 
METHODS  
According to the WHO, IAQGs correspond to safe levels of pollutant concentrations below 
which adverse health effects are not expected to occur in the general population, including 
subgroups considered susceptible due to their health status or age (WHO, 2000). For 
genotoxic carcinogenic compounds, guideline values are expressed as risk levels 
corresponding to a probability of cancer occurring.  
 
The methodological approach developed by the working group is based on three steps for any 
given substance. First, the human and/or animals health effects for inhalation exposure are 
described, taking into account associated durations of exposure (acute, sub-chronic or 
chronic). Susceptible subgroups of populations are identified (AFSSET, 2007). The 
consistency of toxicokinetic and toxicodynamic data, and related effects, is analysed.  
Secondly, existing guideline values and toxicological reference values (TRVs) are collected 
and described: guideline values established within international bodies such as the WHO or 
by the European Commission are collected; guideline values established at a national scale 
(proposed by other bodies or countries) are summarized. In addition, available TRVs for 
inhalation from the US-Environmental Protection Agency-Integrated Risk Information 
System (US-EPA, IRIS), the Agency for Toxic Substances and Disease Registry (ATSDR), 
the Office of Environmental Health Hazard Assessment (OEHHA), Health Canada and the 
Dutch Agency for environmental health (RIVM) are also collected.  
Finally an in-depth critical analysis of available values (guidelines and TRVs) is carried out. 
Duration of exposure, critical health effects, studied populations, point of departure doses 
(NOAEL or LOAEL), safety factors, low-dose extrapolation are specified and discussed. 
IAQGs are proposed if there is one or more already existing guideline value established 
exclusively on health considerations and/or one or more TRV for inhalation. The choice 
among the reliable values is made on a case-by-case basis according to additional criteria (e.g. 
establishment date, animal or human data, etc.). If there is neither a guideline value, nor a 
reliable TRV for inhalation, the working group does not set any IAQG, indicating that 
additional assessment and research are required. 
 
RESULTS AND DISCUSSION 
The available toxicological and epidemiological data indicate that benzene inhalation leads to 
both acute and chronic effects, and allow for a good description and comprehension of 
benzene toxicokinetics and mode of action.  
The observed chronic effects are bone marrow depression expressed as leukopenia, anaemia, 
thrombocytopenia, leading to pancytopenia and aplastic anaemia. A causal relationship exists 
between exposure to benzene or solvents containing benzene at the workplace and the 
development of leukaemia in a rubberworker cohort (Pliofilm). The International Agency for 
Research on Cancer (IARC), the US-EPA and the European Commission have classified 
benzene as a known human carcinogen, respectively, group 1 in 1987, category A in 1998, 
and category 1 in 2004. The analysis of benzene’s mode of action indicates that benzene and 
 
the reactive metabolites cause chromosomal aberrations in humans after chronic exposure. 
Data in animals support the genotoxic action of benzene. 
The AFSSET-CSTB working group has considered benzene as a carcinogenic compound via 
a genotoxic mechanism. Available guidelines and toxicological reference values for 
genotoxic-carcinogenic haematological effects are presented in Table 1. 
 
Table 1. Available guideline and toxicological reference values for non-carcinogenic and 
genotoxic-carcinogenic haematological effects following chronic exposure (scientific review 
until September 2007): 
organization date value study construction 
Chronic exposure – Non carcinogenic effects  
OEHHA 1999 REL = 60 µg.m-3 Tsai et al. 1983 UF =10 
US EPA 2003 RfC = 30 µg.m-3  Rothman et al. 
1996 
UF =300 
ATSDR 2007 MRL = 9.7 µg.m-3 Lan et al. 2004 UF =10 
Chronic exposure – Genotoxic- carcinogenic effects 
WHO 2000 ERUi = 6.10-6 (µg.m-3)-1 Rinsky et al. 
1981 – 1987 
linear and non-linear 
mathematical models 
US EPA 1998 ERUi = 2.2 – 7.8.10-6 (µg.m-3)-1 Rinsky et al. 
1981 – 1987 
linear mathematical 
model 
RIVM 2001 Cr = 2.10-2 mg.m-3 no information no information 
OEHHA 2005 ERUi = 2.9 .10-5 (µg.m-3)-1 not clear no information 
Health 
Canada  
1991 CT0.05 = 15 mg.m-3 Rinsky et 
al.1987 
mathematical model 
 
An analysis of the studies used for the construction of these values was performed. All values 
were determined on the basis of human epidemiological data.  
For non-carcinogenic effects, the ATSDR and the US EPA used a benchmark dose as a 
critical dose to derive the TRV. 240 exposed subjects versus 44 were respectively taken into 
account. Moreover, the study of Lan et al. (2004), which was chosen by ATSDR, was 
considered more appropriate because the characterisation of exposure at low concentrations is 
divided into three levels. The working group proposed the IAQG of 10 g.m-3 to protect the 
general population for long-term exposure (conventionally over 1 year of exposure). 
For carcinogenic-genotoxic effects, the unit risk values for which sufficient data were 
available were discussed. The WHO’s value is based on different models (concentration-
dependent model and multiplicative risk model), using the Pliofilm cohort (Rinsky, 1981; 
Rinsky, 1987) and different exposure matrixes (Crump and Allen, 1984; Paustenbach et al., 
1992; Paustenbach et al., 1993). The geometric mean of the range of excess lifetime risk of 
leukaemia estimates is 6 10-6 (µg.m-3)-1. Since the dose-response relationship remains 
unknown at low concentrations, the use of a concentration-dependent model and a 
multiplicative risk model is considered relevant. The WHO unit risk value of 6 10-6 (µg.m-3)-1, 
published in 2000, was considered as being the most relevant unit risk value by the group. The 
concentrations of benzene associated with an excess lifetime risk of 10-5 and 10-6 are 
respectively 2 and 0.2 g.m-3. The group considers that then the choice of an acceptable risk 
level is the responsibility of policy makers. 
 
CONCLUSIONS 
The methodological approach is relevant to set IAQG recommendation for chronic exposure, 
whatever the health effect is. This approach also allows IAQGs for other exposure duration :  
• for short-term exposure: 30 g.m-3, mean over 14 days; 
• for subchronic exposure: 20 g.m-3 mean over 1 year. 
  
This method was tested and consolidated on several substances. Formaldehyde and carbon 
monoxide IAQGs for acute and chronic exposure were published in 2007. Elaboration of 
IAQGs for tetrachloroethylene, trichloroethylene and naphthalene is ongoing; they will be 
published in 2009. These elaborated guideline values may then been used by policy makers to 
set regulatory levels. 
This work is now also contributing to the development of WHO guidelines for indoor air 
quality initiated by WHO-Europe in 2006. 
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